1. Market Research
  2. > Healthcare Market Trends
  3. > CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France

Summary

Pharmaceuticals market in France is set to decline from $35.5 billion in 2017 to $34.16 billion in 2021, representing a negative compound annual growth rate of 1%.

Despite France’s robust public health insurance system and rising elderly population, increasing pressure on pharmaceutical selling prices, patent expiration of branded drugs and foreign exchange fluctuations are stifling growth. The government is currently focusing on the use of generics as a cost-containment tool to reduce healthcare expenditure. Indeed, the generics market is mainly driven by a favorable regulatory regime and a continuous wave of patent expiries, acting as a barrier to pharmaceutical market growth.

France follows external reference pricing, which is linked with other European countries such as Germany, Spain, Italy, and the UK. A price cut by any of these countries’ governments will quickly translate into price reductions in France, and repeated price cuts have curtailed the rise in healthcare spending.

France’s reimbursement policy is grounded in clinical effectiveness rather than the cost-versus-benefit approach that other countries such as the US and the UK employ. This means that pharmaceutical companies take a higher risk in order to see returns on innovative products, and new drugs have to demonstrate a level of improvement over existing products, which can be seen as a deterrent to investment.

Healthcare companies looking for opportunities within the French market should focus on the growing demand for innovative medicine and biotechnology, which will enable new therapies to command a premium price and influence the value of the market. Financial incentives and tax credits from the French government to support pharmaceutical R&D will promote new prospects for small biotechnology companies, a growing number of which have been operating in France over the past decade.

Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in France, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Novartis, Sanofi, Pfizer, Merck & Co. and Mylan; and profiles and SWOT analyses of the major players in the medical device market: B. Braun Melsungen, Medtronic, Roche, Johnson & Johnson and GlaxoSmithKline (GSK)
- An insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the French healthcare market

Reasons to buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving French healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact France’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

Table Of Contents

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Executive Summary 9
3 Introduction 14
3.1 GlobalData Report Guidance 14
4 Overview of Pharmaceutical and Medical Device Markets 15
4.1 Pharmaceutical Market 15
4.1.1 Market Overview 15
4.1.2 Pharmaceutical Exports and Imports 17
4.1.3 Supply Channels 18
4.1.4 Market Segments 19
4.1.5 Major Therapeutic Areas 25
4.1.6 Major Players 27
4.2 Medical Device Market 65
4.2.1 Market Overview 65
4.2.2 Overview of Top Five Segments 67
4.2.3 Major Players 77
4.3 Market Drivers and Barriers 108
4.3.1 Drivers 108
4.3.2 Barriers 109
5 Market Access 111
5.1 Overview of Healthcare system 111
5.1.1 Reimbursement Process 114
5.1.2 Overview of Insurance Providers 119
5.1.3 Patient Share in Healthcare Expenditure 123
5.1.4 Price Trends in the Healthcare Sector 123
5.1.5 Pricing Policies 124
5.2 Regulatory Landscape 126
5.2.1 Overview of Regulatory Agencies 126
5.2.2 Market Authorization Procedure for Pharmaceutical Products 127
5.2.3 New Medical Device Approval Process 135
5.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 139
5.2.5 Exports and Imports 140
5.2.6 Intellectual Property Rights 141
5.2.7 Clinical Trial Regulations 144
5.2.8 Pharmaceutical Advertising Regulations 145
5.2.9 Pharmacy Regulations 146
5.2.10 Labeling and Packaging Regulations 147
6 Country Analysis 149
6.1 Political Environment 149
6.1.1 Political Structure 149
6.1.2 Current Political Environment 150
6.1.3 Healthcare Policy Initiatives 151
6.2 Economic Landscape 153
6.3 Economic Indicators 155
6.3.1 Gross Domestic Product 155
6.3.2 Gross National Income 158
6.3.3 Inflation 159
6.3.4 Currency Exchange Rate 163
6.3.5 Foreign Direct Investment 164
6.3.6 Foreign Exchange Reserves 165
6.3.7 Trade Balance 166
6.3.8 Government Structural Balance 168
6.3.9 Government Net Debt 169
6.3.10 Major Industries 171
6.4 Demographics 172
6.4.1 Population 172
6.4.2 Education and Literacy 188
6.4.3 Employment 190
6.4.4 Disease Burden 191
6.5 Healthcare Infrastructure 193
6.5.1 Healthcare Facilities 193
6.5.2 Healthcare Parameters 198
6.5.3 Environmental Health 200
6.5.4 Healthcare Personnel 202
6.6 Healthcare Expenditure 205
6.6.1 Overview 205
6.6.2 Share of Public and Private Sectors 206
6.6.3 Major Components of Healthcare Expenditure 207
6.6.4 Spending in Pharmaceutical RandD 208
6.7 Trade Associations 209
6.7.1 France Biotech 209
6.7.2 French Medical Device Association 210
6.7.3 French Pharmaceutical Association 210
6.8 Trade Fairs 210
7 Opportunities and Challenges 212
7.1 Opportunities 212
7.2 Challenges 213
8 Appendix 215
8.1 Abbreviations 215
8.2 Bibliography 218
8.3 Research Methodology 231
8.3.1 Coverage 232
8.3.2 Secondary Research 232
8.3.3 Forecasts 233
8.3.4 Expert Panel 233
8.4 Contact Us 233
8.5 Disclaimer 234

1.1 List of Tables
Table 1: Pharmaceutical Market, France, Revenue ($bn), 2009-2016 16
Table 2: Pharmaceutical Market, France, Revenue ($bn), 2017-2021 17
Table 3: Pharmaceutical Market, France, Exports and Imports ($bn), 2009-2016 18
Table 4: Pharmaceutical Market, France, Generic Pharmaceutical Market Share (%), 2009-2016 21
Table 5: Pharmaceutical Market, France, Market Share of Generics Sold in City Pharmacies (%), 2015 21
Table 6: Pharmaceutical Market, France, Authorized Biosimilars 2015 23
Table 7: Pharmaceutical Market, France, OTC Drug Market Revenue ($bn), 2009-2016 24
Table 8: Pharmaceutical Market, France, Major OTC Drug Classes, Revenue ($bn) and Share (%), 2015 25
Table 9: Pharmaceutical Market, France, Revenue by Major Therapeutic Areas ($bn), 2013 26
Table 10: Major Products, Novartis, Global, 2016 28
Table 11: Late-Stage Pipeline, Novartis, Global, 2015 29
Table 12: Major Products, Sanofi, Global, 2015 37
Table 13: Late-Stage Pipeline, Sanofi, Global, 2015 39
Table 14: Pharmaceutical Market, Pfizer, Late-Stage Pipeline, 2016 45
Table 15: Pharmaceutical Market, Merck and Co., Global, Major Products, 2015 53
Table 16: Pharmaceutical Market, Merck and Co., Global, Late-Stage Pipeline, 2016 54
Table 17: Medical Device Market, France, Revenue ($bn), 2009-2016 66
Table 18: Medical Device Market, France, Revenue ($bn), 2017-2021 67
Table 19: Medical Device Market, France, Revenue ($m) and Market Share (%) by Segment, 2016 68
Table 20: In Vitro Diagnostics Market, France, Revenue ($m), 2009-2016 69
Table 21: In Vitro Diagnostics, France, Revenue ($m) and Market Share (%) of Major Players, 2014 70
Table 22: Orthopedic Device Market, France, Revenue ($m), 2009-2016 71
Table 23: Orthopedic Devices, France, Revenue ($m) and Market Share (%) of Major Players, 2015 72
Table 24: Cardiovascular Device Market, France, Revenue ($m), 2009-2016 73
Table 25: Cardiovascular Devices, France, Revenue ($m) and Market Share (%) of Major Players, 2015 73
Table 26: Wound Care Management Devices, France, Revenue ($m), 2009-2016 74
Table 27: Wound Care Management Devices, France, Revenue ($m) and Market Share (%) of Major Players, 2012 75
Table 28: Ophthalmic Device Market, France, Revenue ($m), 2009-2016 76
Table 29: Ophthalmic Device Market, France, Revenue ($m) and Market Share (%) of Major Players, 2015 77
Table 30: Medical Device Market, France, Revenue ($m) and Market Share (%) of Major Players, 2012 78
Table 31: Medical Device Market, Medtronic, Major Products, 2015 85
Table 32: Roche, Global, Major Products, 2016 91
Table 33: Medical Device Market, Roche, Global, Late-Stage Pipeline, 2016 91
Table 34: Market Access, France, Drug Reimbursement Categories and Rates (%), 2014 119
Table 35: Market Access, France, Source of Public Health Insurance Funding (%), 2015 122
Table 36: Healthcare Expenditure, France, Out-of-Pocket Expenditure (%), 2009-2016 123
Table 37: Market Access, France, Healthcare Consumer Price Index Annual Change (%), 2009-2015 124
Table 38: Economic Indicators, France, GDP per Capita ($), 2009-2016 155
Table 39: Economic Indicators, France, GDP per Capita ($), 2017-2021 156
Table 40: Economic Indicators, France, GDP Annual Growth (%), 2009-2016 157
Table 41: Economic Indicators, France, GDP Annual Growth (%), 2017-2021 158
Table 42: Economic Indicators, France, GNI per Capita ($), 2009-2016 159
Table 43: Economic Indicators, France, Consumer Price Index, 2009-2016 160
Table 44: Economic Indicators, France, Average Consumer Price Index, 2017-2021 161
Table 45: Economic Indicators, France, Average Consumer Price Index Annual Change (%), 2009-2016 162
Table 46: Economic Indicators, France, Average Consumer Price Index, Annual Change (%), 2017-2021 163
Table 47: Economic Indicators, France, Currency Exchange Rate (€/$), 2009-2016 164
Table 48: Economic Indicators, France, Foreign Direct Investment ($bn), 2009-2016 165
Table 49: Economic Indicators, France, Foreign Exchange Reserves ($bn), 2009-2016 166
Table 50: Economic Indicators, France, Imports of Goods and Services ($bn), 2009-2016 167
Table 51: Economic Indicators, France, Exports of Goods and Services ($bn), 2009-2016 168
Table 52: Economic Indicators, France, General Government Structural Balance ($bn), 2009-2016 169
Table 53: Economic Indicators, France, Government Net Debt as a Percentage of GDP (%), 2009-2016 170
Table 54: Economic Indicators, France, Government Net Debt as a Percentage of GDP (%), 2017-2021 171
Table 55: Economic Indicators, France, Value Added by Major Industries ($bn), 2014 172
Table 56: Demographics, France, Population (million), 2009-2016 173
Table 57: Demographics, France, Population (million), 2017-2021 174
Table 58: Demographics, France, Urban-Rural Population Share (%), 2009-2016 175
Table 59: Demographics, France, Urban-Rural Population Share (%), 2017-2021 176
Table 60: Demographics, France, Population Distribution by Age Group (%), 2009-2016 177
Table 61: Demographics, France, Population Distribution by Age Group (%), 2017-2021 178
Table 62: Demographics, France, Births (per 1,000 Population), 2009-2016 179
Table 63: Demographics, France, Mortality (per 1,000 Population), 2009-2016 180
Table 64: Demographics, France, Major Causes of Mortality (%), 2013 181
Table 65: Demographics, France, Mortality Rate of Children Under Five (per 1,000 live births), 2009-2016 182
Table 66: Demographics, France, Immunization Rate (%), 2009-2016 183
Table 67: Demographics, France, Major Causes of Male Mortality (%), 2012 184
Table 68: Demographics, France, Major Causes of Female Mortality (%), 2012 185
Table 69: Demographics, France, Gender Ratio (M/F), 2009-2016 186
Table 70: Demographics, France, Life Expectancy at Birth (years), 2009-2016 187
Table 71: Demographics, France, Life Expectancy at Birth (years), 2017-2021 188
Table 72: Demographics, France, Number of Students by Level of Education (million), 2009-2016 189
Table 73: Demographics, France, Student Enrollment by Specialization (%), 2015 190
Table 74: Demographics, France, Unemployment Rate (%), 2009-2016 191
Table 75: Demographics, France, Disability-Adjusted Life Years by Major Disease (‘000), 2012 192
Table 76: Healthcare Infrastructure, France, Hospitals, 2009-2016 193
Table 77: Healthcare Infrastructure, France, Public and Private Hospitals, 2009-2016 194
Table 78: Healthcare Infrastructure, France, Private Sector Hospitals, 2009-2016 195
Table 79: Healthcare Infrastructure, France, Hospitals Beds by Sector, 2009-2016 196
Table 80: Healthcare Infrastructure, France, Diagnostic Units, 2009-2016 197
Table 81: Healthcare Infrastructure, France, Diagnostic Centers, 2009-2016 198
Table 82: Healthcare Infrastructure, France, Hospitals Beds (per 1,000 population), 2009-2016 199
Table 83: Healthcare Infrastructure, France, Doctors (per 1,000 population), 2009-2016 200
Table 84: Healthcare Infrastructure, France, PM2.5 (µg per m³), 2009-2016 201
Table 85: Healthcare Infrastructure, France, CO2 Emissions (metric tons per capita), 2009-2016 202
Table 86: Healthcare Infrastructure, France, Nurses (per 1,000 population), 2009-2016 203
Table 87: Healthcare Infrastructure, France, Pharmacists, 2009-2016 204
Table 88: Healthcare Infrastructure, France, Dentists, 2009-2016 205
Table 89: Healthcare Infrastructure, France, Healthcare Expenditure as Percentage of GDP (%), 2009-2016 206
Table 90: Healthcare Infrastructure, France, Public-Private Share of Expenditure (%), 2009-2016 207
Table 91: Healthcare Infrastructure, France, Major Components of Healthcare Expenditure (%), 2015 208
Table 92: Healthcare Infrastructure, France, Pharmaceutical RandD Expenditure ($ per capita), 2009-2016 209
Table 93: Healthcare Expenditure, France, Major Healthcare Trade Fairs, 2017 211

1.2 List of Figures
Figure 1: Pharmaceutical Market, France, Revenue ($bn), 2009-2021 10
Figure 2: Medical Device Market, France, Revenue ($bn), 2009-2021 11
Figure 3: Country Profile, France, 2016 13
Figure 4: Pharmaceutical Market, France, Revenue ($bn), 2009-2016 16
Figure 5: Pharmaceutical Market, France, Revenue ($bn), 2017-2021 17
Figure 6: Pharmaceutical Market, France, Exports and Imports ($bn), 2009-2016 18
Figure 7: Pharmaceutical Market, France, Distribution Channels (%), 2016 19
Figure 8: Pharmaceutical Market, France, Generic Pharmaceutical Market Share (%), 2009-2016 21
Figure 9: Pharmaceutical Market, France, OTC Drug Market Revenue ($bn), 2009-2016 24
Figure 10: Pharmaceutical Market, France, Major OTC Drug Classes (Share%), 2015 25
Figure 11: Pharmaceutical Market, France, Revenue by Major Therapeutic Areas ($bn), 2013 26
Figure 12: Medical Device Market, France, Revenue ($bn), 2009-2016 66
Figure 13: Medical Device Market, France, Revenue ($bn), 2017-2021 67
Figure 14: Medical Device Market, France, Revenue by Segment ($m), 2016 68
Figure 15: In Vitro Diagnostics Market, France, Revenue ($m), 2009-2016 69
Figure 16: In Vitro Diagnostics, France, Market Share of Major Players (%), 2014 69
Figure 17: Orthopedic Device Market, France, Revenue ($m), 2009-2016 71
Figure 18: Orthopedic Device Market, France, Market Share of Major Players (%), 2015 71
Figure 19: Cardiovascular Device Market, France, Revenue ($m), 2009-2016 72
Figure 20: Cardiovascular Devices, France, Market Share of Major Players (%), 2015 73
Figure 21: Wound Care Management Devices, France, Revenue ($m), 2009-2016 74
Figure 22: Wound Care Management Devices, France, Market Share of Major Players (%), 2012 75
Figure 23: Ophthalmic Device Market, France, Revenue ($m), 2009-2016 76
Figure 24: Ophthalmic Device Market, France, Market Share of Major Players (%), 2015 77
Figure 25: Medical Device Market, France, Revenue of Major Players ($m), 2012 78
Figure 26: Healthcare Market, France, Drivers and Barriers, 2017 111
Figure 27: Market Access, France, Healthcare System, 2014 113
Figure 28: Market Access, France, Key Influencers in Reimbursement Procedure, 2016 114
Figure 29: Market Access, France, Pricing and Reimbursement Process, 2016 115
Figure 30: Market Access, France, Roles of Transparency Commission in Reimbursement Procedure, 2014 116
Figure 31: Market Access, France, Pricing Procedure, 2016 118
Figure 32: Market Access, France, Public Health Insurance Schemes, 2015 121
Figure 33: Market Access, France, Source of Public Health Insurance Funding (%), 2015 122
Figure 34: Healthcare Expenditure, France, Out-of-Pocket Expenditure (%), 2009-2016 123
Figure 35: Market Access, France, Healthcare Consumer Price Index Annual Change (%), 2009-2015 124
Figure 36: Market Access, France, Organizational Structure of the Drug Regulatory Authority, 2016 127
Figure 37: Market Access, EU, Centralized Procedure for Market Authorization, Pre-Submission, 2016 131
Figure 38: Market Access, EU, Centralized Procedure, Market Authorization, Pre-opinion Phase, 2016 132
Figure 39: Market Access, EU, Centralized Procedure, Market Authorization, Post-opinion Phase, 2016 133
Figure 40: Market Access, EU, Decentralized Procedure, Market Authorization, 2016 134
Figure 41: Market Access, EU, Conformity Assessment of Class I Medical Devices, 2016 136
Figure 42: Market Access, EU, Conformity Assessment of Class IIa Medical Devices, 2016 137
Figure 43: Market Access, EU, Conformity Assessment of Class IIb Medical Devices, 2016 138
Figure 44: Market Access, EU, Conformity Assessment of Class III Medical Devices, 2016 139
Figure 45: Market Access, France, Patent Approval Process, 2016 142
Figure 46: Market Access, France, Trademark Approval Process, 2016 144
Figure 47: Economic Indicators, France, GDP Per Capita ($), 2009-2016 155
Figure 48: Economic Indicators, France, GDP per Capita ($), 2017-2021 156
Figure 49: Economic Indicators, France, GDP Annual Growth (%), 2009-2016 157
Figure 50: Economic Indicators, France, GDP Annual Growth (%), 2017-2021 158
Figure 51: Economic Indicators, France, GNI per Capita ($), 2009-2016 159
Figure 52: Economic Indicators, France, Consumer Price Index, 2009-2016 160
Figure 53: Economic Indicators, France, Average Consumer Price Index, 2017-2021 161
Figure 54: Economic Indicators, France, Average Consumer Price Index, Annual Change (%), 2009-2016 162
Figure 55: Economic Indicators, France, Average Consumer Price Index, Annual Change (%), 2017-2021 163
Figure 56: Economic Indicators, France, Currency Exchange Rate (€/$), 2009-2016 164
Figure 57: Economic Indicators, France, Foreign Direct Investment ($bn), 2009-2016 165
Figure 58: Economic Indicators, France, Foreign Exchange Reserves ($bn), 2009-2016 166
Figure 59: Economic Indicators, France, Imports of Goods and Services ($bn), 2009-2016 167
Figure 60: Economic Indicators, France, Exports of Goods and Services ($bn), 2009-2016 168
Figure 61: Economic Indicators, France, Government Structural Balance ($bn), 2009-2016 169
Figure 62: Economic Indicators, France, Government Net Debt as a Percentage of GDP (%), 2009-2016 170
Figure 63: Economic Indicators, France, Government Net Debt as a Percentage of GDP (%), 2017-2021 171
Figure 64: Economic Indicators, France, Value Added by Major Industries ($bn), 2014 172
Figure 65: Demographics, France, Population (million), 2009-2016 173
Figure 66: Demographics, France, Population (million), 2017-2021 174
Figure 67: Demographics, France, Urban-Rural Population Share (%), 2009-2016 175
Figure 68: Demographics, France, Urban-Rural Population Share (%), 2017-2021 176
Figure 69: Demographics, France, Population Distribution by Age Group (%), 2009-2016 177
Figure 70: Demographics, France, Population Distribution by Age Group (%), 2017-2021 178
Figure 71: Demographics, France, Births (per 1,000 Population), 2009-2016 179
Figure 72: Demographics, France, Mortality (per 1,000 Population), 2009-2016 180
Figure 73: Demographics, France, Major Causes of Mortality (%), 2013 181
Figure 74: Demographics, France, Mortality Rate of Children Under Five (per 1,000 live births), 2009-2016 182
Figure 75: Demographics, France, Immunization Rate (%), 2009-2016 183
Figure 76: Demographics, France, Major Causes of Male Mortality (%), 2012 184
Figure 77: Demographics, France, Major Causes of Female Mortality (%), 2012 185
Figure 78: Demographics, France, Gender Ratio (M/F), 2009-2016 186
Figure 79: Demographics, France, Life Expectancy at Birth (years), 2009-2016 187
Figure 80: Demographics, France, Life Expectancy at Birth (years), 2017-2021 188
Figure 81: Demographics, France, Number of Students by Level of Education (million), 2009-2016 189
Figure 82: Demographics, France, Student Enrollment by Specialization (%), 2015 190
Figure 83: Demographics, France, Unemployment Rate (%), 2009-2016 191
Figure 84: Demographics, France, Major Diseases, Disability-Adjusted Life Years by Major Disease (‘000s), 2012 192
Figure 85: Healthcare Infrastructure, France, Hospitals, 2009-2016 193
Figure 86: Healthcare Infrastructure, France, Public and Private Hospitals, 2009-2016 194
Figure 87: Healthcare Infrastructure, France, Private Sector Hospitals, 2009-2016 195
Figure 88: Healthcare Infrastructure, France, Hospitals Beds by Sector, 2009-2016 196
Figure 89: Healthcare Infrastructure, France, Diagnostic Units (per million population), 2009-2016 197
Figure 90: Healthcare Infrastructure, France, Diagnostic Centers, 2009-2016 198
Figure 91: Healthcare Infrastructure, France, Hospitals Beds (per 1,000 population), 2009-2016 199
Figure 92: Healthcare Infrastructure, France, Doctors (per 1,000 population), 2009-2016 200
Figure 93: Healthcare Infrastructure, France, PM2.5 (µg per m³), 2009-2016 201
Figure 94: Healthcare Infrastructure, France, CO2 Emissions (metric tons per capita), 2009-2016 202
Figure 95: Healthcare Infrastructure, France, Nurses (per 1,000 population), 2009-2016 203
Figure 96: Healthcare Infrastructure, France, Pharmacists, 2009-2016 204
Figure 97: Healthcare Infrastructure, France, Dentists, 2009-2016 205
Figure 98: Healthcare Infrastructure, France, Healthcare Expenditure as Percentage of GDP (%), 2009-2016 206
Figure 99: Healthcare Infrastructure, France, Public-Private Share of Expenditure (%), 2009-2016 207
Figure 100: Healthcare Infrastructure, France, Major Components of Healthcare Expenditure (%), 2015 208
Figure 101: Healthcare Infrastructure, France, Pharmaceutical RandD Expenditure ($ per capita), 2009-2016 209
Figure 102: Healthcare Market, France, Opportunities and Challenges, 2016 214

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Healthcare IT Market by Product End User - Global Forecast to 2021

Healthcare IT Market by Product End User - Global Forecast to 2021

  • $ 8150
  • Industry report
  • March 2017
  • by MarketsandMarkets

The global healthcare IT market is expected to grow at a CAGR of 15.9% from 2016 to 2021 and reach USD 280.25 billion. Growing need to manage regulatory compliance through healthcare IT solutions, government ...

Ultrasound Market by Technology, Display, Portability, Application, End User - Forecast to 2021

Ultrasound Market by Technology, Display, Portability, Application, End User - Forecast to 2021

  • $ 7150
  • Industry report
  • March 2017
  • by MarketsandMarkets

The ultrasound market is expected to reach USD 6.86 billion by 2021 at a CAGR of 5.2% during 2016-2021. North America and Europe held the largest share of the market in 2016; however, the Asia-Pacific ...

EU5 Computed Tomography (CT) Systems Market Outlook to 2022

EU5 Computed Tomography (CT) Systems Market Outlook to 2022

  • $ 5995
  • Industry report
  • February 2017
  • by GlobalData

EU5 Computed Tomography (CT) Systems Market Outlook to 2022 Summary GlobalData’s new report, "EU5 Computed Tomography (CT) Systems Market Outlook to 2022", provides key market data on the EU5 Computed ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.